As known, mutations in TDP-43 may influence its aggregation, dysfunction, axonal transportation and even RNA granule formation, implying the possible amyloidogenic and neurotoxic properties of TDP-43 mutants in ALS and FTLD. This evidence concerns the gene TARDBP and amyotrophic lateral sclerosis.